$AMSC
AMERICAN SUPERCONDUCTOR CORP /DE/ Stock $amsc

$amsc Overview Financials Valuation SEC Filings Company Website

2020 Form 10-K Financial Statement

#000143774920012276 Filed on June 02, 2020

Income Statement

Concept	2020	2019 Q2	2019 Q1
Revenue	$63.84M	$13.77M	$14.59M
YoY Change	13.58%	9.23%	8.09%
Cost Of Revenue	$54.39M	$12.19M	$11.83M
YoY Change	28.92%	39.92%	12.56%
Gross Profit	$9.445M	$1.577M	$2.760M
YoY Change	-32.62%	-59.49%	-7.69%
Gross Profit Margin	14.8%	11.45%	18.92%
Selling, General & Admin	$22.67M	$5.255M	$5.720M
YoY Change	2.91%	-9.18%	1.96%
% of Gross Profit	240.01%	333.23%	207.25%
Research & Development	$9.565M	$2.473M	$2.300M
YoY Change	-3.13%	-12.92%	-20.69%
% of Gross Profit	101.27%	156.82%	83.33%
Depreciation & Amortization	$4.000M	$1.100M	$1.150M
YoY Change	-6.98%	0.0%	-48.2%
% of Gross Profit	42.35%	69.75%	41.67%
Operating Expenses	$32.57M	$7.813M	$8.100M
YoY Change	-262.82%	-13.39%	-5.81%
Operating Profit	-$23.13M	-$6.236M	-$5.340M
YoY Change	-167.98%	21.61%	-8.06%
Interest Expense	$1.327M	$505.0K	-$720.0K
YoY Change	18.8%	151.24%	46.94%
% of Operating Profit
Other Income/Expense, Net	$253.0K	-$543.0K	$540.0K
YoY Change	-84.18%	-189.16%	-254.29%
Pretax Income	-$16.90M	-$3.328M	-$6.520M
YoY Change	-151.0%	-30.41%	-1.95%
Income Tax	$195.0K	$211.0K	$130.0K
% Of Pretax Income
Net Earnings	-$17.10M	-$3.539M	-$8.350M
YoY Change	-163.88%	-25.29%	39.28%
Net Earnings / Revenue	-26.78%	-25.7%	-57.23%
Basic Earnings Per Share	-$0.81	-$0.17
Diluted Earnings Per Share	-$1.03	-$0.17	-$408.5K
COMMON SHARES
Basic Shares Outstanding	20.99M	20.51M	21.42M shares
Diluted Shares Outstanding	21.07M	20.51M

Balance Sheet

Concept	2020	2019 Q2	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$54.80M	$74.00M	$77.50M
YoY Change	-29.29%	176.12%	127.27%
Cash & Equivalents	$24.70M	$73.95M	$77.48M
Short-Term Investments	$30.10M
Other Short-Term Assets	$3.500M	$4.100M	$3.100M
YoY Change	12.9%	-12.77%	6.9%
Inventory	$19.00M	$11.92M	$12.12M
Prepaid Expenses
Receivables	$17.00M	$10.74M	$7.855M
Other Receivables	$0.00	$0.00	$2.800M
Total Short-Term Assets	$94.30M	$100.7M	$103.4M
YoY Change	-8.8%	56.52%	53.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.90M	$8.747M	$8.972M
YoY Change	32.22%	-24.29%	-28.3%
Goodwill		$1.719M	$1.719M
YoY Change		0.0%	0.0%
Intangibles		$2.805M	$2.890M
YoY Change		-10.81%	-10.53%
Long-Term Investments	$5.000M		$0.00
YoY Change
Other Assets	$7.600M	$306.0K	$279.0K
YoY Change	216.67%	8.13%	2.95%
Total Long-Term Assets	$29.80M	$19.44M	$15.93M
YoY Change	87.42%	-3.31%	-24.13%
TOTAL ASSETS
Total Short-Term Assets	$94.30M	$100.7M	$103.4M
Total Long-Term Assets	$29.80M	$19.44M	$15.93M
Total Assets	$124.1M	$120.2M	$119.3M
YoY Change	4.02%	42.28%	35.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.00M	$4.088M	$2.939M
YoY Change	244.83%	5.82%	-5.07%
Accrued Expenses	$10.90M	$7.800M	$9.000M
YoY Change	21.11%	-4.88%	0.0%
Deferred Revenue		$10.81M	$7.557M
YoY Change		-0.18%	-43.95%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$41.00M	$28.74M	$28.38M
YoY Change	44.37%	1.72%	3.88%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$10.80M	$51.00K	$93.00K
YoY Change	33.33%	-47.96%	63.16%
Total Long-Term Liabilities	$10.80M	$51.00K	$93.00K
YoY Change	33.33%	-47.96%	63.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$41.00M	$28.74M	$28.38M
Total Long-Term Liabilities	$10.80M	$51.00K	$93.00K
Total Liabilities	$51.90M	$41.74M	$38.14M
YoY Change	36.22%	14.33%	6.1%
SHAREHOLDERS EQUITY
Retained Earnings		-$965.1M	-$961.5M
YoY Change		-2.36%	-2.71%
Common Stock		$1.045B	$1.045B
YoY Change		0.31%	0.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$2.384M	$2.101M
YoY Change		26.54%	27.72%
Treasury Stock Shares			$235.5K
Shareholders Equity	$72.20M	$78.41M	$81.19M
YoY Change
Total Liabilities & Shareholders Equity	$124.1M	$120.2M	$119.3M
YoY Change	4.02%	42.28%	35.33%

Cashflow Statement

Concept	2020	2019 Q2	2019 Q1
OPERATING ACTIVITIES
Net Income	-$17.10M	-$3.539M	-$8.350M
YoY Change	-163.88%	-25.29%	39.28%
Depreciation, Depletion And Amortization	$4.000M	$1.100M	$1.150M
YoY Change	-6.98%	0.0%	-48.2%
Cash From Operating Activities	-$16.50M	-$5.866M	-$5.080M
YoY Change	-138.62%	-14.81%	10.43%
INVESTING ACTIVITIES
Capital Expenditures	$3.630M	$836.0K	-$240.0K
YoY Change	281.3%	626.96%	-40.0%
Acquisitions
YoY Change
Other Investing Activities	-$8.000K	-$94.00K	$3.060M
YoY Change	-105.56%	-284.31%	-82.07%
Cash From Investing Activities	-$36.62M	$2.259M	$2.820M
YoY Change	-1788.38%	-1460.84%	-83.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.776M	-283.0K	90.00K
YoY Change	-2031.77%	18.91%	0.0%
NET CHANGE
Cash From Operating Activities	-16.50M	-5.866M	-5.080M
Cash From Investing Activities	-36.62M	2.259M	2.820M
Cash From Financing Activities	5.776M	-283.0K	90.00K
Net Change In Cash	-47.33M	-3.531M	-2.170M
YoY Change	-207.7%	-51.85%	-117.86%
FREE CASH FLOW
Cash From Operating Activities	-$16.50M	-$5.866M	-$5.080M
Capital Expenditures	$3.630M	$836.0K	-$240.0K
Free Cash Flow	-$20.13M	-$6.702M	-$4.840M
YoY Change	-148.19%	-4.27%	15.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q1	amsc	Accrued Inventories In Transit AccruedInventoriesInTransit	763000
CY2019Q1	amsc	Accrued Inventories In Transit AccruedInventoriesInTransit	244000
CY2020Q1	amsc	Cash Cash Equivalents And Marketable Securities CashCashEquivalentsAndMarketableSecurities	59900000
CY2020	amsc	Change In Fair Value Of Warrants Due To Exercise ChangeInFairValueOfWarrantsDueToExercise	-83000
CY2019	amsc	Change In Fair Value Of Warrants Due To Exercise ChangeInFairValueOfWarrantsDueToExercise
CY2020	amsc	Contract With Customer Asset Deferred Program Costs Change In Contract Costs ContractWithCustomerAssetDeferredProgramCostsChangeInContractCosts	4844000
CY2019	amsc	Contract With Customer Asset Deferred Program Costs Change In Contract Costs ContractWithCustomerAssetDeferredProgramCostsChangeInContractCosts	1585000
CY2020	amsc	Contract With Customer Asset Deferred Program Costs Contract Costs Recognized ContractWithCustomerAssetDeferredProgramCostsContractCostsRecognized	-3525000
CY2019	amsc	Contract With Customer Asset Deferred Program Costs Contract Costs Recognized ContractWithCustomerAssetDeferredProgramCostsContractCostsRecognized	-2212000
CY2019	amsc	Contract With Customer Asset Deferred Program Costs Impact Of Adoption Of Asc606 ContractWithCustomerAssetDeferredProgramCostsImpactOfAdoptionOfASC606	-1599000
CY2019Q1	amsc	Contract With Customer Asset Deferred Program Costs Net ContractWithCustomerAssetDeferredProgramCostsNet	318000
CY2020Q1	amsc	Contract With Customer Asset Deferred Program Costs Net ContractWithCustomerAssetDeferredProgramCostsNet	1631000
CY2018Q1	amsc	Contract With Customer Asset Deferred Program Costs Net ContractWithCustomerAssetDeferredProgramCostsNet	2567000
CY2020	amsc	Contract With Customer Asset Deferred Program Costs Other Changes ContractWithCustomerAssetDeferredProgramCostsOtherChanges	-6000
CY2019	amsc	Contract With Customer Asset Deferred Program Costs Other Changes ContractWithCustomerAssetDeferredProgramCostsOtherChanges	-14000
CY2020	amsc	Contract With Customer Asset Deferred Program Costs Revenue Recognized ContractWithCustomerAssetDeferredProgramCostsRevenueRecognized
CY2019	amsc	Contract With Customer Asset Deferred Program Costs Revenue Recognized ContractWithCustomerAssetDeferredProgramCostsRevenueRecognized	-9000
CY2020	amsc	Contract With Customer Asset Unbilled Ar Change In Time Frame Performance Obligation Satisfied Revenue Recognized ContractWithCustomerAssetUnbilledARChangeInTimeFramePerformanceObligationSatisfiedRevenueRecognized	-11516000
CY2019	amsc	Contract With Customer Asset Unbilled Ar Change In Time Frame Performance Obligation Satisfied Revenue Recognized ContractWithCustomerAssetUnbilledARChangeInTimeFramePerformanceObligationSatisfiedRevenueRecognized	-12076000
CY2020	amsc	Contract With Customer Asset Unbilled Ar Decrease Due To Cost Recognition On Completed Performance Obligation ContractWithCustomerAssetUnbilledARDecreaseDueToCostRecognitionOnCompletedPerformanceObligation
CY2019	amsc	Contract With Customer Asset Unbilled Ar Decrease Due To Cost Recognition On Completed Performance Obligation ContractWithCustomerAssetUnbilledARDecreaseDueToCostRecognitionOnCompletedPerformanceObligation
CY2019	amsc	Contract With Customer Asset Unbilled Ar Impact Of Adoption Of Asc606 ContractWithCustomerAssetUnbilledARImpactOfAdoptionOfASC606
CY2019Q1	amsc	Contract With Customer Asset Unbilled Ar Net ContractWithCustomerAssetUnbilledARNet	2213000
CY2020Q1	amsc	Contract With Customer Asset Unbilled Ar Net ContractWithCustomerAssetUnbilledARNet	5711000
CY2018Q1	amsc	Contract With Customer Asset Unbilled Ar Net ContractWithCustomerAssetUnbilledARNet	3016000
CY2020	amsc	Contract With Customer Asset Unbilled Ar Other Changes ContractWithCustomerAssetUnbilledAROtherChanges	-3000
CY2019	amsc	Contract With Customer Asset Unbilled Ar Other Changes ContractWithCustomerAssetUnbilledAROtherChanges	-51000
CY2020	amsc	Contract With Customer Asset Unbilled Ar Revenue Recognized ContractWithCustomerAssetUnbilledARRevenueRecognized	15017000
CY2019	amsc	Contract With Customer Asset Unbilled Ar Revenue Recognized ContractWithCustomerAssetUnbilledARRevenueRecognized	11324000
CY2019	amsc	Contract With Customer Liability Impact Of Adoption Of Asc606 ContractWithCustomerLiabilityImpactOfAdoptionOfASC606	-2657000
CY2020	amsc	Contract With Customer Liability Other Changes ContractWithCustomerLiabilityOtherChanges	-247000
CY2019	amsc	Contract With Customer Liability Other Changes ContractWithCustomerLiabilityOtherChanges	-1215000
CY2020Q1	amsc	Deferred Tax Assets Fixed Assets And Intangible Assets DeferredTaxAssetsFixedAssetsAndIntangibleAssets	1697000
CY2019Q1	amsc	Deferred Tax Assets Fixed Assets And Intangible Assets DeferredTaxAssetsFixedAssetsAndIntangibleAssets	1553000
CY2020Q1	amsc	Deferred Tax Liabilities Intercompany Debt DeferredTaxLiabilitiesIntercompanyDebt	14365000
CY2019Q1	amsc	Deferred Tax Liabilities Intercompany Debt DeferredTaxLiabilitiesIntercompanyDebt	16028000
CY2020	amsc	Defined Contribution Plan Company Contribution Percentage Match Common Stock DefinedContributionPlanCompanyContributionPercentageMatchCommonStock	0.5
CY2020	amsc	Defined Contribution Plan Percentage Of First Eligible Employee Contribution Matched By Employer DefinedContributionPlanPercentageOfFirstEligibleEmployeeContributionMatchedByEmployer	0.06
CY2020	amsc	Effective Income Tax Rate Reconciliation True Up Of Net Operating Loss Percentage EffectiveIncomeTaxRateReconciliationTrueUpOfNetOperatingLossPercentage	0.01
CY2019	amsc	Effective Income Tax Rate Reconciliation True Up Of Net Operating Loss Percentage EffectiveIncomeTaxRateReconciliationTrueUpOfNetOperatingLossPercentage	-0.6
CY2020	amsc	Gain Loss In Change Of Fair Value Of Derivative Instruments And Warrants GainLossInChangeOfFairValueOfDerivativeInstrumentsAndWarrants	4648000
CY2019	amsc	Gain Loss In Change Of Fair Value Of Derivative Instruments And Warrants GainLossInChangeOfFairValueOfDerivativeInstrumentsAndWarrants	-3725000
CY2020	amsc	Gain Loss In Change Of Fair Value Of Warrants Net Of Tax GainLossInChangeOfFairValueOfWarrantsNetOfTax	4648000
CY2019	amsc	Gain Loss In Change Of Fair Value Of Warrants Net Of Tax GainLossInChangeOfFairValueOfWarrantsNetOfTax
CY2019	amsc	Impact Of Adoption Of Accounting Standards Update ImpactOfAdoptionOfAccountingStandardsUpdate	33000
CY2019Q1	amsc	Notes And Loans Receivable Current Portion Of Unamortized Debt Discount NotesAndLoansReceivableCurrentPortionOfUnamortizedDebtDiscount	112000
CY2019Q1	amsc	Notes And Loans Receivable Noncurrent Portion Of Unamortized Debt Discount NotesAndLoansReceivableNoncurrentPortionOfUnamortizedDebtDiscount
CY2020Q1	amsc	Operating Loss Carryforwards Indefinite OperatingLossCarryforwardsIndefinite	54000000
CY2020	amsc	Revenue Performance Obligation Satisfied Revenue Recognized Percentage RevenuePerformanceObligationSatisfiedRevenueRecognizedPercentage	0.72
CY2020	amsc	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	6433000
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0000880807
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22636686
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	354748
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019Q3	dei	Entity Public Float EntityPublicFloat	163900000
CY2020	dei	Entity Registrant Name EntityRegistrantName	AMERICAN SUPERCONDUCTOR CORP /DE/
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2020	dei	Trading Symbol TradingSymbol	amsc
CY2020Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	22091000
CY2019Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	15885000
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	10045000
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2939000
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16987000
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7855000
CY2020Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	933000
CY2019Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3363000
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	40081000
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	40560000
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-216000
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5000
CY2020Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1053507000
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1044622000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3030000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1922000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1922000
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3030000
CY2020	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	340000
CY2019	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	340000
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-308000
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-224000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	907988
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2020Q1	us-gaap	Assets Assets	124109000
CY2019Q1	us-gaap	Assets Assets	119330000
CY2020Q1	us-gaap	Assets Current AssetsCurrent	94277000
CY2019Q1	us-gaap	Assets Current AssetsCurrent	103398000
CY2020Q1	us-gaap	Billed Contract Receivables BilledContractReceivables	11276000
CY2019Q1	us-gaap	Billed Contract Receivables BilledContractReceivables	5642000
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24699000
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	77483000
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	78198000
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34249000
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30864000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-47334000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	43949000
CY2020Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22902288
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21651631
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22604410
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21413113
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	229000
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	216000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17307000
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	25873000
CY2019Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	15521000
CY2020Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	26142000
CY2018Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	21937000
CY2020	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	47877000
CY2019	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	20540000
CY2020Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	18430000
CY2019Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7557000
CY2020Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7712000
CY2019Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7962000
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-37009000
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-23084000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	54393000
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	42190000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1814000
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1246000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	95000
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	4399000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1909000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5645000
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	407000
CY2019	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	457000
CY2020	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	100000
CY2019	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	0
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1524000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1588000
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-190000
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-853000
CY2019Q1	us-gaap	Deferred Gain On Sale Of Property DeferredGainOnSaleOfProperty
CY2020Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1551000
CY2019Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1357000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1714000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	735000
CY2020Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	16002000
CY2019Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	17822000
CY2020Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	180000
CY2019Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1698000
CY2020Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	217362000
CY2019Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	213822000
CY2020Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	13244000
CY2019Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	13046000
CY2020Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1371000
CY2020Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	17373000
CY2019Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	17482000
CY2020Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	195504000
CY2019Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	181657000
CY2020Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1565000
CY2019Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2785000
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	5352000
CY2019Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	14781000
CY2020Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	199989000
CY2019Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	196340000
CY2019Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	340000
CY2020Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1637000
CY2019Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1794000
CY2020Q1	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	200000
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	300000
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	300000
CY2020Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	666000
CY2019Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	631000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4308000
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4609000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4000000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4300000
CY2020Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent
CY2019Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	4942000
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.81
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.32
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.03
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8000
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-635000
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.01
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.19
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.24
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.92
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.02
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.04
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.06
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.03
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	0.01
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	0.37
CY2020Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5683000
CY2019Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5404000
CY2020	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal
CY2019	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	127000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4648000
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3725000
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-3725000
CY2020Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0
CY2018Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1217000
CY2019Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4942000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1135000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	483000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	483000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	483000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	483000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	483000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3550000
CY2019Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2890000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	100000
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1600000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	319000
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized
CY2020	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement
CY2019	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	52698000
CY2020Q1	us-gaap	Goodwill Goodwill	1719000
CY2019Q1	us-gaap	Goodwill Goodwill	1719000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-18260000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16901000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	33141000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1359000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	57430000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	195000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6380000
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020	us-gaap	Gross Profit GrossProfit	9445000
CY2019	us-gaap	Gross Profit GrossProfit	14017000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-24289000
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3653000
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2859000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5894000
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2839000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9159000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	529000
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	10788000
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2773000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8143000
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-5007000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-373000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	365000
CY2020	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	84000
CY2019	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	391
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3550000
CY2019Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2890000
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1327000
CY2019	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1117000
CY2020Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5260000
CY2019Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4405000
CY2020Q1	us-gaap	Inventory For Long Term Contracts Or Programs InventoryForLongTermContractsOrPrograms	1631000
CY2019Q1	us-gaap	Inventory For Long Term Contracts Or Programs InventoryForLongTermContractsOrPrograms	318000
CY2020Q1	us-gaap	Inventory Net InventoryNet	18975000
CY2019Q1	us-gaap	Inventory Net InventoryNet	12119000
CY2020Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	10739000
CY2019Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	5474000
CY2020Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1300000
CY2019Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	900000
CY2020Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1345000
CY2019Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1922000
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	1276000
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	878000
CY2020	us-gaap	Lease Cost LeaseCost	1357000
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	565000
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	456000
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1000000
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	35000000
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3630000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4387000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1394000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	665000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	501000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	559000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	621000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	647000
CY2020Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	948000
CY2020Q1	us-gaap	Liabilities Liabilities	51890000
CY2019Q1	us-gaap	Liabilities Liabilities	38137000
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	124109000
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	119330000
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	40960000
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	28384000
CY2020Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0
CY2020Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	30149000
CY2019Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent
CY2020Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	5046000
CY2019Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5776000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-299000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-36621000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2169000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16497000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	42714000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-17096000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	26761000
CY2020	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-21662000
CY2019	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	26761000
CY2019Q1	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	3000000
CY2019Q1	us-gaap	Notes And Loans Receivable Gross Noncurrent NotesAndLoansReceivableGrossNoncurrent
CY2019Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	2888000
CY2020Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent
CY2019Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2020	us-gaap	Operating Expenses OperatingExpenses	32574000
CY2019	us-gaap	Operating Expenses OperatingExpenses	-20006000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-23129000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	34023000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	713000
CY2019Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3821000
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3439000
CY2019Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	309000
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	439000
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent
CY2019Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3512000
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3000000
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3795000
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3359000
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset
CY2019Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0706
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0708
CY2019Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y251D
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y332D
CY2019	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1300000
CY2020Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1986000
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1759000
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	385000
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	279000
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-211000
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-888000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-211000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-888000
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	38000
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	93000
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-329000
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	852000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	253000
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1599000
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-8000
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	144000
CY2019	us-gaap	Payments For Restructuring PaymentsForRestructuring	885000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	952000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1922000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	3030000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	28500
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	7.22
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	389174
CY2019	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	951000
CY2020	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	542000
CY2020Q1	us-gaap	Preconfirmation Restricted Cash And Cash Equivalents Current PreconfirmationRestrictedCashAndCashEquivalentsCurrent	500000
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2959000
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3053000
CY2020	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	202000
CY2019	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	157000
CY2020	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments
CY2019	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	127000
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3001000
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3138000
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6139000
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2019Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1545000
CY2018Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1769000
CY2020Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	2015000
CY2020Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2015000
CY2019Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1545000
CY2020	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	72000
CY2019	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	727000
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	48646000
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49532000
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8565000
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8972000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9565000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9874000
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	508000
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	5657000
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	715000
CY2019	us-gaap	Restructuring Charges RestructuringCharges	450000
CY2020	us-gaap	Restructuring Charges RestructuringCharges
CY2018Q1	us-gaap	Restructuring Reserve RestructuringReserve	435000
CY2019Q1	us-gaap	Restructuring Reserve RestructuringReserve
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-978635000
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-961539000
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	63838000
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	56207000
CY2020Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	61400000
CY2020Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	8200000
CY2020Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22669000
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22028000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.74
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	953948
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	982247
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.26
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	6.26
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	332375
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	6.21
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.665
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.018
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	134342
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	51.68
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	29923
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	296.62
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5939
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	164265
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140281
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	96.30
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	49.95
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	140061
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	50.01
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	11
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	5383000
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y332D
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y328D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y332D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y229D
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	544000
CY2019	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	327000
CY2020	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	342000
CY2019	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	157000
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	100000
CY2020Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding
CY2019Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	600000
CY2019Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1700000
CY2019Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4600000
CY2018Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3600000
CY2018Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1300000
CY2018Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1600000
CY2018Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1100000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21069000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20726000
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	201000
CY2019	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	52229000
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	81193000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	72219000
CY2020Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	297878
CY2019Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	235518
CY2020Q1	us-gaap	Treasury Stock Value TreasuryStockValue	2666000
CY2019Q1	us-gaap	Treasury Stock Value TreasuryStockValue	2101000
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	456000
CY2020	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	565000
CY2020Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	5711000
CY2019Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	2213000
CY2020Q1	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	1900000
CY2019Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are <div style="display: inline; font-style: italic; font: inherit;">not</div> readily apparent from other sources. On an ongoing basis, the Company evaluates its estimates, including those related to revenue recognition, collectability of receivables, realizability of inventory, goodwill and intangible assets, warranty provisions, stock-based compensation, tax reserves, and deferred tax assets. Provisions for depreciation are based on their estimated useful lives using the straight-line method. Some of these estimates can be subjective and complex and, consequently, actual results <div style="display: inline; font-style: italic; font: inherit;"> may </div>differ from these estimates under different assumptions or conditions. While for any given estimate or assumption made by the Company’s management there <div style="display: inline; font-style: italic; font: inherit;"> may </div>be other estimates or assumptions that are reasonable, the Company believes that, given the current facts and circumstances, it is unlikely that applying any such other reasonable estimate or assumption would materially impact the financial statements.</div></div></div></div></div></div></div>
CY2020	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	953000
CY2019	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	930000
CY2020	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	21937000
CY2019	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	21265000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20985000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20335000

Files In Submission

Name	View Source	Status
0001437749-20-012276-index-headers.html	Edgar Link	pending
0001437749-20-012276-index.html	Edgar Link	pending
0001437749-20-012276.txt	Edgar Link	pending
0001437749-20-012276-xbrl.zip	Edgar Link	pending
amsc-20200331.xml	Edgar Link	completed
amsc-20200331.xsd	Edgar Link	pending
amsc-20200331_cal.xml	Edgar Link	unprocessable
amsc-20200331_def.xml	Edgar Link	unprocessable
amsc-20200331_lab.xml	Edgar Link	unprocessable
amsc-20200331_pre.xml	Edgar Link	unprocessable
amsc20200331_10k.htm	Edgar Link	pending
ex_171764.htm	Edgar Link	pending
ex_171765.htm	Edgar Link	pending
ex_171766.htm	Edgar Link	pending
ex_171767.htm	Edgar Link	pending
ex_171768.htm	Edgar Link	pending
ex_171769.htm	Edgar Link	pending
ex_187341.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
graph.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMSC
AMERICAN SUPERCONDUCTOR CORP /DE/ Stock $amsc

2020 Form 10-K Financial Statement

#000143774920012276 Filed on June 02, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMSC AMERICAN SUPERCONDUCTOR CORP /DE/ Stock $amsc

2020 Form 10-K Financial Statement

#000143774920012276 Filed on June 02, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMSC
AMERICAN SUPERCONDUCTOR CORP /DE/ Stock $amsc